Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase I/II Study of Cediranib and Olaparib in Combination for Treatment of Recurrent Papillary-Serous Ovarian, Fallopian Tube, or Peritoneal Cancer or for Treatment of Recurrent Triple-Negative Breast Cancer
Brief Summary: This partially randomized phase I/II trial studies the side effects and the best dose of cediranib maleate and olaparib and to see how well they work compared to olaparib alone in treating patients with ovarian, fallopian tube, peritoneal, or triple-negative breast cancer that has returned after a period of improvement (recurrent). Cediranib maleate may help keep cancer cells from growing by affecting their blood supply. Olaparib may stop cancer cells from growing abnormally. The combination of cediranib maleate and olaparib may be safe, tolerable and/or effective in treating patients with recurrent ovarian, fallopian tube, or peritoneal cancer or recurrent triple-negative breast cancer.


Options:
A: Arm Label: Arm 1 (ceralasertib+olaparib); Type: EXPERIMENTAL; Interventions: Drug: Olaparib, Drug: Ceralasertib | Arm Label: Arm 2 (olaparib monotherapy); Type: EXPERIMENTAL; Interventions: Drug: Olaparib | Arm Label: Arm 3 (placebo); Type: EXPERIMENTAL; Interventions: Drug: Placebo to match olaparib | Intervention Type: DRUG; Name: Olaparib; Assigned to Arm(s): Arm 1 (ceralasertib+olaparib), Arm 2 (olaparib monotherapy) | Intervention Type: DRUG; Name: Ceralasertib; Assigned to Arm(s): Arm 1 (ceralasertib+olaparib) | Intervention Type: DRUG; Name: Placebo to match olaparib; Assigned to Arm(s): Arm 3 (placebo)
B: Arm Label: Arm A; Type: EXPERIMENTAL; Interventions: Drug: Rucaparib, Drug: Nivolumab | Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Drug: Rucaparib, Drug: Placebo IV Infusion | Arm Label: Arm C; Type: EXPERIMENTAL; Interventions: Drug: Nivolumab, Drug: Placebo Oral Tablet | Arm Label: Arm D; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo Oral Tablet, Drug: Placebo IV Infusion | Arm Label: Japanese Open-label Safety Cohort; Type: EXPERIMENTAL; Interventions: Drug: Rucaparib, Drug: Nivolumab | Intervention Type: DRUG; Name: Rucaparib; Assigned to Arm(s): Arm A, Arm B, Japanese Open-label Safety Cohort | Intervention Type: DRUG; Name: Nivolumab; Assigned to Arm(s): Arm A, Arm C, Japanese Open-label Safety Cohort | Intervention Type: DRUG; Name: Placebo Oral Tablet; Assigned to Arm(s): Arm C, Arm D | Intervention Type: DRUG; Name: Placebo IV Infusion; Assigned to Arm(s): Arm B, Arm D
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: AZD2281 | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: matching placebo | Intervention Type: DRUG; Name: AZD2281; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: matching placebo; Assigned to Arm(s): 2
D: Arm Label: Arm I (cediranib maleate and olaparib); Type: EXPERIMENTAL; Interventions: Procedure: Biopsy Procedure, Procedure: Biospecimen Collection, Drug: Cediranib Maleate, Procedure: Computed Tomography, Procedure: Echocardiography Test, Procedure: Magnetic Resonance Imaging, Procedure: Multigated Acquisition Scan, Drug: Olaparib | Arm Label: Arm II (olaparib); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Biopsy Procedure, Procedure: Biospecimen Collection, Procedure: Computed Tomography, Procedure: Echocardiography Test, Procedure: Magnetic Resonance Imaging, Procedure: Multigated Acquisition Scan, Drug: Olaparib | Intervention Type: PROCEDURE; Name: Biopsy Procedure; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib) | Intervention Type: PROCEDURE; Name: Biospecimen Collection; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib) | Intervention Type: DRUG; Name: Cediranib Maleate; Assigned to Arm(s): Arm I (cediranib maleate and olaparib) | Intervention Type: PROCEDURE; Name: Computed Tomography; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib) | Intervention Type: PROCEDURE; Name: Echocardiography Test; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib) | Intervention Type: PROCEDURE; Name: Magnetic Resonance Imaging; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib) | Intervention Type: PROCEDURE; Name: Multigated Acquisition Scan; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib) | Intervention Type: DRUG; Name: Olaparib; Assigned to Arm(s): Arm I (cediranib maleate and olaparib), Arm II (olaparib)

Answer: D